Based on their levels, we divided the HCC patients into two groups that high group indicates the expression of HDGF and SREBP‐1 are both high‐level and low‐level group indicating the expression of HDGF and SREBP‐1 are both negative. The gene discussed is SREBF1; the disease is hepatocellular carcinoma.